KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Accumulated Expenses (2016 - 2024)

Historic Accumulated Expenses for Quest Diagnostics (DGX) over the last 13 years, with Q4 2024 value amounting to $306.0 million.

  • Quest Diagnostics' Accumulated Expenses rose 662.02% to $306.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $306.0 million, marking a year-over-year increase of 662.02%. This contributed to the annual value of $306.0 million for FY2024, which is 662.02% up from last year.
  • Per Quest Diagnostics' latest filing, its Accumulated Expenses stood at $306.0 million for Q4 2024, which was up 662.02% from $287.0 million recorded in Q4 2023.
  • In the past 5 years, Quest Diagnostics' Accumulated Expenses ranged from a high of $460.0 million in Q4 2021 and a low of $287.0 million during Q4 2023
  • For the 5-year period, Quest Diagnostics' Accumulated Expenses averaged around $360.2 million, with its median value being $356.0 million (2020).
  • As far as peak fluctuations go, Quest Diagnostics' Accumulated Expenses surged by 5964.13% in 2020, and later tumbled by 2678.57% in 2023.
  • Quest Diagnostics' Accumulated Expenses (Quarter) stood at $356.0 million in 2020, then increased by 29.21% to $460.0 million in 2021, then decreased by 14.78% to $392.0 million in 2022, then fell by 26.79% to $287.0 million in 2023, then increased by 6.62% to $306.0 million in 2024.
  • Its Accumulated Expenses was $306.0 million in Q4 2024, compared to $287.0 million in Q4 2023 and $392.0 million in Q4 2022.